Dr. Robin L. Smith, MD, MBA, age 59, is a global business leader, medical doctor, author, and entrepreneur in the healthcare industry. She is a trailblazer in regenerative medicine, predictive analytics, and wellness and has been focused on turnarounds, M&A, and disruptive innovations driving interest and growth to her companies, the most recent of which is Exotropin Inc. Dr. Smith received her B.A. degree from Yale University and her M.D. degree from the Yale School of Medicine. She holds an M.B.A. degree from the Wharton School of Business. Dr. Smith is co-author of “Cells Are the New Cure” and “The Healing Cell:” A thought leader in health, she has spoken to diverse audiences in interviews and talks at prestigious venues such as the Future Investment Initiative, Lake Nona Impact Forum, and the Vatican. Dr. Smith is president and chairman of the board of the Cura Foundation and has been active in many other nonprofit organizations, including serving on the board of directors of the NYU Langone Medical Center, Sanford Health, the NYU Hospital for Joint Diseases, and the Alliance for Regenerative Medicine. Dr. Smith also has extensive experience serving on the board of directors of multiple private and public companies.
